Sign in

CIK 0001027838 · Accelerated filer

TACTILE SYSTEMS TECHNOLOGY INC

Sign in to watch
Ticker
TCMD
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
MN
Entity type
operating
Phone
866-435-3948
Business address
1331 TYLER STREET NE STE 200, MINNEAPOLIS, MN, 55413
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$255,000
in 2 filings, $255K under 10b5-1 plans

Net −$255,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. BURKE WILLIAM W −$135K Director sold 9% of stake
  2. King Laura G. −$120K Director sold 19% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-02-20 Birkemeyer Elaine M. Chief Financial Officer Grant or award 10b5-1 +36,248 107,876
2025-02-20 King Laura G. Director Grant or award +2,970 2,970
2025-02-20 Dodd Sheri Louise Chief Executive Officer Grant or award +20,108 118,721
2025-02-20 Dodd Sheri Louise Chief Executive Officer Grant or award +65,669 184,390
2024-08-12 Ferstler Sherri Lee Senior VP, Sales Sale −1,550 $13.07 $20K 38,764
2024-08-07 Dodd Sheri Louise Chief Executive Officer Grant or award +64,959 98,613
2024-05-16 Birkemeyer Elaine M. Chief Financial Officer Sale −3,041 $13.68 $42K 61,295
2024-05-08 BURKE WILLIAM W Director Sale 10b5-1 −2,500 $14.06 $35K 25,273
2024-05-08 BURKE WILLIAM W Director Grant or award 10b5-1 +10,469 35,742
2024-05-08 Asbury Valerie L. Director Grant or award +10,469 32,744
2024-05-08 Dodd Sheri Louise Director Grant or award +10,469 33,654
2024-05-08 Huggenberger Raymond Director Grant or award +10,469 40,242
2024-05-08 Shafer David Brent Director Grant or award +10,469 32,744
2024-05-08 Volkart Carmen B Director Grant or award +10,469 21,620
2024-05-08 Washington Boyd Vindell Director Grant or award +10,469 19,169
2024-05-06 Burns Kristie Sr. VP Mktg & Clinical Affairs Sale −815 $14.37 $12K 62,574
2024-02-29 Burns Kristie Sr. VP Mktg & Clinical Affairs Sale 10b5-1 −243 $15.25 $4K 63,389
2024-02-29 REUVERS DANIEL L. President and CEO Sale 10b5-1 −1,396 $15.25 $21K 238,027
2024-02-27 Burns Kristie Sr. VP Mktg & Clinical Affairs Sale 10b5-1 −1,091 $15.58 $17K 63,632
2024-02-27 REUVERS DANIEL L. President and CEO Sale 10b5-1 −4,689 $15.60 $73K 239,423

Page 4 of 8 · 141 trades